Steven Gillis, Director at bluebird bio, Inc. (BLUE), sold 115,000 shares at $35.25 ($4.1M) on 2014-10-09, disclosed to the SEC on 2014-10-14.
Open-market sale of $4.1M BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| VBIV | BUY | 2023-07-18 | $2.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |